Latest Biotech News

Progen and Avexa to merge

Wednesday 31 December 2008

Trophos receives €7 million to further neurology and cardiology products

Tuesday 30 December 2008

Oncothyreon licenses assets and restructures

Tuesday 23 December 2008

Denmark's Epitherapeutics receives funding for cancer drug R&D

Thursday 18 December 2008

Panacos slashes workforce after forced loan repayment

Monday 15 December 2008

BMS signs cancer deal with Exelixis
Bristol-Myers Squibb has acquired the development and commercialisation rights to two of Exelixis's novel small-molecule inhibitors for cancer...
Monday 15 December 2008

Norwegian government to fund biotech growth

Thursday 11 December 2008

UK biotech leaders demand government investment for its survival
Sir Christopher Evans, head of the biotech fund manager Excalibur, and 21 other leading figures in UK biotech are calling on the UK government to make significant investment in the sector to ensure its survival.
Monday 8 December 2008

Enzon drops biotech spin-off plans
Enzon Pharmaceuticals has abandoned plans to spin off an oncology focused biotech business owing to external market conditions. The firm had intended to form two independent public companies to optimise the business, research and capital requirements.
Thursday 4 December 2008

Scrip Pharma and Biotech Stock Tracker - October 2008

In Scrip's Stock Tracker for October, US reporter Christopher Spillane reviews the impact of recent political intervention and global turmoil on both the capital markets in general and the 15 biopharmaceuticals stocks followed in this monthly feature.
Stock Tracker - October 2008

Previous 1 2 3 4 5 6 7 8 Next

Email to a friend

• Facebook
• digg
• del.icio.us
• furl